Clinical Trials Logo

Clinical Trial Summary

This is a multicenter, Phase 2 study to assess the feasibility, safety and efficacy of OTO-104 given by intratympanic administration in subjects at risk for ototoxicity from cisplatin chemotherapy regimens in the treatment of cancer.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT02997189
Study type Interventional
Source Otonomy, Inc.
Status Terminated
Phase Phase 2
Start date November 15, 2016
Completion date September 26, 2017